Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Saras Subur Abadi is a prominent Indonesian pharmaceutical distribution company specializing in the importation and marketing of Traditional Chinese Medicine (TCM) and health supplements. Established as a successor to the long-standing PT Saras Subur Ayoe, the company serves as the exclusive agent for several renowned international brands, including Pien Tze Huang and Yunnan Baiyao. Their business model focuses on bridging the gap between global manufacturers and the Indonesian healthcare market through an extensive distribution network. The company's portfolio covers a wide range of therapeutic areas, from wound care and anti-inflammatories to liver health and general wellness products. PT Saras Subur Abadi plays a critical role in ensuring that regulated and authentic traditional medicines are accessible to the Indonesian public through pharmacies and healthcare providers. The company maintains a strong commitment to regulatory compliance, working closely with the Indonesian National Agency of Drug and Food Control (BPOM).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PT. Saras Subur Abadi.